Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.55 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.55 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | RAB9A | P51151 | 5/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | F2 | P00734 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.49 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 4/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16604044 | 0.85 | TDP1 (0.59) | TDP1MAPK1HIF1ASLC6A2SLC6A3 | |
| SCHEMBL28875175 | 0.85 | TDP1 (0.68) | TDP1MAPK1HIF1ASLC6A2SLC6A3 | |
| SCHEMBL51601 | 0.85 | TDP1 (0.68) | TDP1MAPK1HIF1ASLC6A2SLC6A3 | |
| SCHEMBL14978089 | 0.83 | TDP1 (0.56) | TDP1MAPK1HIF1ASLC6A2SLC6A3 | |
| SCHEMBL4737513 | 0.83 | NSD2 (0.63) | L3MBTL1 | |
| SCHEMBL5021063 | 0.83 | TDP1 (0.56) | TDP1MAPK1HIF1ASLC6A2SLC6A3 | |
| SCHEMBL2853034 | 0.82 | TDP1 (0.66) | TDP1MAPK1HIF1ASLC6A2SLC6A3 | |
| SCHEMBL5021052 | 0.81 | TDP1 (0.54) | TDP1MAPK1HIF1ASLC6A2SLC6A3 | |
| SCHEMBL21953404 | 0.81 | TDP1 (0.67) | TDP1MAPK1HIF1ASLC6A2SLC6A3 | |
| SCHEMBL29140273 | 0.81 | ALOX15 (0.56) | TDP1KMT2AALDH1A1RAB9ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117510338-A | Natural naphthoquinone derivative and preparation method and application thereof | 贵州大学 | 2024-02-06 | — | — | CN | claimed |
| US-20160068655-A1 | INTEGRATED PROCESS FOR THE PRODUCTION OF BENZOATE PLASTICIZERS | EASTMAN CHEMICAL COMPANY (US) | 2016-03-10 | — | — | US | claimed |
| CN-103896965-A | Heterocyclic substituted styrene compound and application thereof | UNIV EAST CHINA SCIENCE & TECH | 2014-07-02 | — | — | CN | claimed |
| JP-4295454-A | — | — | None | — | — | JP | disclosed |
| CN-114787667-B | Optical laminate, polarizing plate, image display device, and touch panel | 富士胶片株式会社 | 2024-03-22 | — | — | CN | disclosed |
| CN-117510338-A | Natural naphthoquinone derivative and preparation method and application thereof | 贵州大学 | 2024-02-06 | — | — | CN | disclosed |
| WO-2020063999-A1 | MONO HALOGEN OR METHYL-SUBSTITUTED 5-HT2B ANTAGONISTS WITH INCREASED ACTIVITY | NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) | 2020-04-02 | — | — | WO | disclosed |
| US-9464184-B2 | Container and composition for enhanced gas barrier properties | THE COCA-COLA COMPANY (US) | 2016-10-11 | — | — | US | disclosed |
| US-9359488-B2 | Pet container and compositions having enhanced mechanical properties and gas barrier properties and methods | THE COCA-COLA COMPANY (US) | 2016-06-07 | — | — | US | disclosed |
| US-20160068655-A1 | INTEGRATED PROCESS FOR THE PRODUCTION OF BENZOATE PLASTICIZERS | EASTMAN CHEMICAL COMPANY (US) | 2016-03-10 | — | — | US | disclosed |
| US-20150232641-A1 | CONTAINER AND COMPOSITION FOR ENHANCED GAS BARRIER PROPERTIES | THE COCA-COLA COMPANY (US) | 2015-08-20 | — | — | US | disclosed |
| US-8110265-B2 | Pet container and compositions having enhanced mechanical properties and gas barrier properties | THE COCA-COLA COMPANY (US) | 2012-02-07 | — | — | US | disclosed |
| CN-102285936-A | 4-thiazolidone carboxylic acid derivative and preparation method and application thereof | — | 2011-12-21 | — | — | CN | disclosed |
| US-20100143546-A1 | CONTAINER AND COMPOSITION FOR ENHANCED GAS BARRIER PROPERTIES | THE COCA-COLA COMPANY (US) | 2010-06-10 | — | — | US | disclosed |
| US-20100143547-A1 | Pet Container And Compositions Having Enhanced Mechanical Properties And Gas Barrier Properties | COCA-COLA COMPANY (US) | 2010-06-10 | — | — | US | disclosed |
| CN-100400512-C | Benzoic acid derivatives as modulators of PPAR alpha and gamma | ASTRAZENECA AB (SE) | 2008-07-09 | — | — | CN | disclosed |
| CN-1662230-A | Benzoic acid derivatives as modulators of PPAR alpha and gamma | ASTRAZENECA AB (SE) | 2005-08-31 | — | — | CN | disclosed |
| EP-1517680-A1 | BENZOIC ACID DERIVATIVES AS MODULATORS OF PPAR ALPHA AND GAMMA | Astrazeneca AB (SE) | 2005-03-30 | — | — | EP | disclosed |
| WO-2004000295-A1 | BENZOIC ACID DERIVATIVES AS MODULATORS OF PPAR ALPHA AND GAMMA | ASTRAZENECA AB (SE) | 2003-12-31 | — | — | WO | disclosed |
| JP-H04295454-A | PROCESS FOR PRODUCING E-OXIME EHTER OF PHENYLGLYOXYLIC ESTER | BASF AG | 1992-10-20 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160068655-A1 | INTEGRATED PROCESS FOR THE PRODUCTION OF BENZOATE PLASTICIZERS | ADH5, PAOX, ADH1C | TDP1 1227/4885MAPK1 3296/4885HIF1A 480/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.